RxDoctor Payments Data

James Walker, MD

Family Medicine · Pendleton, SCNPI 1871533505

Payments from drug & device makers

$6,751in general payments, 2019–2025

Across 457 payments — averaging $14.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • AbbVie$1K
  • Lilly USA, LLC$732
  • AstraZeneca$457
  • Pfizer$330
  • Otsuka America Pharmaceutical, Inc.$319
  • plus $2K from 36 others

What the payments were for

  • Food & beverage$6,69999%
  • Education$521%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,751 in reported general payments places this provider in the 90th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$232,830
Medicare patients
460
Services billed
4,241

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban112$112,456
MounjaroTirzepatide88$104,964
TrulicityDulaglutide70$88,703
JardianceEmpagliflozin63$72,552
RexultiBrexpiprazole23$52,668
MyrbetriqMirabegron56$44,635
CreonLipase/Protease/Amylase20$21,166
ProliaDenosumab12$20,032
OzempicSemaglutide16$18,784
XareltoRivaroxaban18$17,949
EntrestoSacubitril/Valsartan25$17,459
FarxigaDapagliflozin Propanediol21$15,256
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$14,382
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$13,389
SymbicortBudesonide/Formoterol Fumarate44$10,914

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$732$193,667158 claims
PfizerEliquis$330$112,456112 claims
Boehringer IngelheimJardiance$14$72,55263 claims
Otsuka America Pharmaceutical, Inc.Rexulti$319$52,66823 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$457$40,55186 claims
AbbVieCreon, Linzess$1,196$30,99138 claims
GSKTrelegy Ellipta, Breo Ellipta$174$20,21933 claims
AmgenProlia$44$20,03212 claims
Novo NordiskOzempic$299$18,78416 claims
Johnson & JohnsonXarelto$55$17,94918 claims
NovartisEntresto$242$17,45925 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Pendleton

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →